Ozempic and the Postpartum Period: What You Should Know
You may have heard of Ozempic (semaglutide)—a medication originally developed to manage type 2 diabetes, now commonly prescribed for weight loss. Understandably, some new parents are curious if it’s safe to use postpartum, especially while breastfeeding. Here’s what current research and clinical guidance tell us.
What We Know from the Evidence
Breastfeeding and Infant Exposure
A 2024 study published in Breastfeeding Medicine found very low levels of semaglutide in breast milk—less than 1% of the maternal dose, with no immediate adverse effects reported in infants. However, the study involved only a few participants and did not measure long-term effects.
Animal Studies Raise Caution
Reproductive studies in animals have shown that semaglutide can affect fetal development, including growth restriction and skeletal abnormalities. While these findings do not directly translate to humans, they have led both Health Canada and the FDA to recommend avoiding Ozempic during pregnancy and breastfeeding.
Nutritional Considerations
Ozempic slows digestion, reduces appetite, and can lead to weight loss. For postpartum individuals—especially those breastfeeding—this could impact nutritional intake and potentially milk supply. While not directly studied, this is an important consideration during recovery.
Oral Ozempic (Rybelsus)
There is no safety data for oral versions of Ozempic in breastfeeding populations. Due to their enhanced absorption mechanisms, they are currently not recommended during lactation.
At Nurture North, we support evidence-based, compassionate care for postpartum wellness. While Ozempic may be appropriate for some non-lactating individuals in consultation with their care provider, the research advises caution if you are breastfeeding or early in your recovery journey.
We have resources found in the Directory page of this website that will link you to holistic approaches to postpartum support—including therapeutic massage, mental health resources, and gentle nutritional care—to promote healing, energy, and long-term wellbeing.
If you’re navigating complex decisions about medication, recovery, or emotional health, we’re here to help direct you to the right professionals and hold space for those conversations—without judgment.
References
Diab, T., et al. (2024). Semaglutide Concentrations in Human Milk and Infant Safety Following Maternal Exposure. Breastfeeding Medicine. PubMed ID: 39275201
U.S. National Library of Medicine. LactMed Database: Semaglutide. https://www.ncbi.nlm.nih.gov/books/NBK500980
The Breastfeeding Mama. (2024). GLP-1 Medications While Breastfeeding. https://www.thebreastfeedingmama.com/blog/glp1-medications-while-breastfeeding
Health Canada Drug Monograph: Ozempic (semaglutide) product safety information
